Fish oil containing lipid emulsions in critically ill patients: Critical analysis and future perspectives;Emulsiones lipídicas con aceite de pescado en el paciente crítico: Análisis crítico y perspectivas futuras

Medicina Intensiva

Volumn 40, Issue 1, 2016, Pages 39-45

  Manzanares, W ^a   Langlois, P L ^b  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Critically ill patient; Fish oils; Lipid emulsion; Omega 3 fatty acids; Parenteral nutrition

Indexed keywords

FISH OIL; LIPID EMULSION; SOYBEAN OIL;

ARTICLE; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; HUMAN; INCIDENCE; INFECTION; LENGTH OF STAY; META ANALYSIS (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); CRITICAL ILLNESS; PARENTERAL NUTRITION;

CRITICAL ILLNESS; FAT EMULSIONS, INTRAVENOUS; FISH OILS; HUMANS; PARENTERAL NUTRITION; SOYBEAN OIL;

EID: 84958747012     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2015.07.006     Document Type: Article

References (34)

1. Teitelbaum DH, Guenter P, Griebel D, Abrams SA, Bark S, Baker M, et al. Proceedings from FDA/A.S.P.E.N. Public workshop: clinical trial design for intravenous fat emulsion products, October 29, 2013. JPEN J Parenter Enteral Nutr. 2014; Epub ahead of print.
2. Manzanares W., Dhaliwal R., Jurewitsch B., Stapleton R.D., Jeejeebhoy K.N., Heyland D.K. Alternative lipid emulsions in the critically ill: A systematic review of the evidence. Intensive Care Med 2013, 39:1683-1694.
3. Ren T., Cong L., Wang Y., Tang Y., Tian B., Lin X., et al. Lipid emulsions in parenteral nutrition: Current applications and future developments. Expert Opin Drug Deliv. 2013, 10:1533-1549.
4. Mayer K., Gokorsch S., Fegbeutel C., Hattar K., Rosseau S., Walmrath D., et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003, 167:1321-1328.
5. Mayer K., Fegbeutel C., Hattar K., Sibelius U., Krämer H.J., Heuer K.U., et al. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: Impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003, 29:1472-1481.
6. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem. 2001, 276:16683-16689.
7. Gonzalez-Periz A., Planaguma A., Gronert K., Miquel R., López-Parra M., Titos E., et al. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: Protectin D1 and 17S-hydroxy-DHA. FASEB J. 2006, 20:2537-2539.
8. O'Keefe J.H, Abuissa H., Sastre A., Steinhaus D.M., Harris W.S. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006, 97:1127-1130.
9. Singer P., Shapiro H., Theilla M., Anbar R., Singer J., Cohen J. Antiinflammatory properties of omega-3 fatty acids in critical illness: Novel mechanisms and an integrative perspective. Intensive Care Med. 2008, 34:1580-1592.
10. Wang X., Li W., Li N., Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A randomized and controlled study. JPEN J Parenter Enteral Nutr 2008, 32:236-241.
11. Han Y.Y., Lai S.L., Ko W.J., Chou C.H., Lai H.S. Effects of fish oil on inflammatory modulation in surgical intensive care unit patients. Nutr Clin Pract 2012, 27:91-98.
12. Terashima M., Aoyama-Ishikawa M., Ueda T., Hagi A., Usami M., Nakao A., et al. The effects of n-3 polyunsaturated fatty acid-rich total parenteral nutrition on neutrophil apoptosis in a rat endotoxemia. J Clin Biochem Nutr 2013, 52:154-159.
13. Kohama K., Nakao A., Terashima M., Aoyama-Ishikawa M., Shimizu T., Harada D., et al. Supplementation of parenteral nutrition with fish oils attenuates acute lung injury in a rat model. J Clin Biochem Nutr 2014, 54:116-121.
14. Hecker M., Ott J., Sondermann C., Schaefer M.B., Obert M., Hecker A., et al. Immunomodulation by fish-oil containing lipid emulsions in murine acute respiratory distress syndrome. Crit Care. 2014, 18:R85.
15. Manzanares W., Langlois P.L., Dhaliwal R., Lemieux M., Heyland D.K. Intravenous fish oil lipid emulsions in critically ill patients: An updated systematic review and meta-analysis. Crit Care 2015, 19:167.
16. Grecu I., Mirea L., Grintescu I. Parenteral fish oil supplementation in patients with abdominal sepsis [abstract]. Clin Nutr. 2003, 22:S23.
17. Friesecke S., Lotze C., Kohler J., Heinrich A., Felix S.B., Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: A randomized controlled trial. Intensive Care Med. 2008, 34:1411-1420.
18. Wang X., Li W., Zhang F., Pan L., Li N., Li J. Fish oil-supplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: A randomized controlled trial. Inflammation 2009, 32:304-309.
19. Barbosa V.M., Miles E.A., Calhau C., Lafuente E., Calder P.C. Effects of fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: A randomized, controlled clinical trial. Crit Care. 2010, 14:R5.
20. Gupta A., Govil D., Bhatnagar S., Gupta S., Goyal J., Patel S., et al. Efficacy and safety of parenteral omega-3 fatty acids in ventilated patients with acute lung injury. Indian J Crit Care Med. 2011, 15:108-113.
21. Khor B.S., Liaw S.J., Shih H.C., Wang L.S. Randomized, double blind, placebo-controlled trial of fish-oil based lipid emulsion infusion for treatment of critically ill patients with severe sepsis. Asian J Surg. 2011, 34:1-10.
22. Burkhart C.S., Dell-Kuster S., Siegemund M., Pargger H., Marsch S., Strebel S.P., et al. Effect of n-3 fatty acids on markers of brain injury and incidence of sepsis-associated delirium in septic patients. Acta Anaesthesiol Scand. 2014, 58:689-700.
23. Gultekin G., Sahin H., Inanc N., Uyanik F., Ok E. Impact of omega-3 and Omega-9 fatty acids enriched total parenteral nutrition on blood chemistry and inflammatory markers in septic patients. Pak J Med Sci. 2014, 30:299-304.
24. Hall T.C., Bilku D.K., Al-Leswas D., Neal C.P., Horst C., Cooke J., et al. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically Ill patients with sepsis: A pilot study. JPEN J Parenter Enteral Nutr. 2015, 39:301-312.
25. Grau-Carmona T., Bonet-Saris A., García-de-Lorenzo A., Sánchez-Alvarez C., Rodríguez-Pozo A., Acosta-Escribano J., et al. Influence of n-3 polyunsaturated fatty acids enriched lipid emulsions on nosocomial infections and clinical outcomes in critically ill patients: ICU Lipids Study. Crit Care Med. 2015, 43:32-39.
26. Pradelli L., Mayer K., Muscaritoli M., Heller A.R. n-3 fatty acid enriched parenteral nutrition regimens in elective surgical and ICU patients: A meta-analysis. Crit Care. 2012, 16:R184.
27. Palmer A.J., Ho C.K.M., Ajibola O., Avenell A. The role of n-3 fatty acid supplemented parenteral nutrition in critical illness in adults: A systematic review and meta-analysis. Crit Care Med. 2013, 41:307-316.
28. Manzanares W., Dhaliwal R., Jurewitsch B., Stapleton R.D., Jeejeebhoy K.N., Heyland D.K. Parenteral fish oil lipid emulsions in the critically ill: A systematic review and meta-analysis. JPEN J Parenter Enteral Nutr. 2014, 38:20-28.
29. Bonet Saris A, Márquez Vácaro JA, Serón Arbeloa C. Recomendaciones para el soporte nutricional y metabólico especializado del paciente crítico. Actualización. Consenso SEMICYUC-SENPE: Requerimientos de macronutrientes y micronutrientes. Med Intensiva. 2011; 35 (Supl 1):17-21.
30. Vaquerizo Alonso C., Mesejo A., Acosta Escribano J., Ruiz Santana S. Manejo de la nutrición parenteral en las Unidades de Cuidados Intensivos en España. Nutr Hosp. 2013, 28:1498-1507. Grupo de trabajo PARENTTE.
31. Canadian Clinical Practice Guidelines [consultado Julio 2015]. Disponible en: www.criticalcarenutrition.com.
32. Berger M.M., Delodder F., Liaudet L., Tozzi P., Schlaepfer J., Chiolero R.L., et al. Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: A randomized controlled trial. Am J Clin Nutr 2013, 97:246-254.
33. Larsen B.M., Goonewardene L.A., Joffe A.R., Van Aerde J.E., Field C.J., Olstad D.L., et al. Pre-treatment with an intravenous lipid emulsion containing fish oil (eicosapentaenoic and docosahexaenoic acid) decreases inflammatory markers after open-heart surgery in infants: A randomized, controlled trial. Clin Nutr 2012, 31:322-329.
34. Fish OIL optimal dosE Determination study. Clinical Trials.gov NCT01146821 [consultado 27 Jun 2015]. Disponible en: www.criticalcarenutrition.com.